Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.